Larvol Delta - Marker-Therapeutics-Announces-Sustained-Complete-Response-in-First-Lymphoma-Patient-Treated-with-MT601-following-CAR-T-Relapse

MT-601 - Marker Therap

https://www.globenewswire.com/news-release/2023/12/11/2793733/0/en/Marker-Therapeutics-Announces-Sustained-Complete-Response-in-First-Lymphoma-Patient-Treated-with-MT-601-following-CAR-T-Relapse.html

Dec 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next